Adam Maeder

Stock Analyst at Piper Sandler

(1.66)
# 1652
Out of 5,438 analysts
146
Total ratings
Success rate
Average return
22 Stocks
Name Action PT Current % Upside Ratings Updated
RBOT Vicarious Surgical
Maintains: Neutral
9 7
9.29 -24.65% 8 Aug 13, 2025
INSP Inspire Medical Syst...
Maintains: Overweight
233 150
79.67 88.28% 15 Aug 5, 2025
RMD ResMed
Maintains: Neutral
248 270
284.43 -5.07% 4 Aug 1, 2025
EW Edwards Lifesciences
Maintains: Overweight
83 90
78.21 15.07% 16 Jul 25, 2025
ISRG Intuitive Surgical
Reiterates: Overweight
575 595
471.96 26.07% 20 Jul 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
18 10
6.64 50.6% 2 Jul 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
4 4
4.11 -2.68% 1 Jun 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
5 4
2.58 55.04% 4 May 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25 14
12.17 15.04% 3 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
133 145
131.33 10.41% 3 Apr 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
6 6
5.84 0.17% 16 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
52 80
79.97 0.04% 7 Jan 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
20 21
12.12 73.27% 2 May 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
18 20
27.49 -27.25% 6 May 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
290 360
334.75 7.54% 10 Apr 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
7 8
3.92 104.08% 1 Mar 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
15 20
6.97 186.94% 8 Mar 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
75 71
n/a n/a 8 Jan 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
6 5
2.54 96.85% 2 Mar 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
10 18
1.42 1167.61% 2 Jan 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
104 99
49.57 99.72% 3 May 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
9 11
10 10% 5 Jun 14, 2021